Ouro Medicines

Series-A
ouromedicines.com Biotech & Healthcare San Francisco, United States Founded 2025 11–50 employees
Total Funding $120M
Latest Round $120M Series-A
Last Announced Jan 10, 2025
Investors 8 Backers
Decision Makers 5 Available

About Ouro Medicines

Ouro Medicines is a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Francisco, United States
Year Founded 2025
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website ouromedicines.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $120,000,000 · Series-A

    Backed by NEA

  2. Milestone

    Company founded

    San Francisco, United States

Investors & Backers

8
NEA
Lead
Boyu Capital
GSK
LongRiver Investments
Monograph Capital
Norwest Venture Partners
TPG
UPMC Enterprises

Funding History

1 Round
Series-A equity · Jan 10, 2025

Round backers: NEA

Founders & Leadership

4

Christina Carlson

General Counsel and Chief Administrative Officer

Work email & phone locked Unlock →

Jaideep Dudani

Founder

Work email & phone locked Unlock →

Kevin Baker

Chief Development Officer

Work email & phone locked Unlock →

Neely Mozaffarian

CMO and Head of Development

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts